LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,540 Cr | ₹3,112 Cr | ₹2,432 Cr | ₹2,681 Cr | ₹2,457 Cr |
What is the latest Total Current Liabilities ratio of LAURUS LABS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹3,540 Cr |
Mar2024 | ₹3,112 Cr |
Mar2023 | ₹2,432 Cr |
Mar2022 | ₹2,681 Cr |
Mar2021 | ₹2,457 Cr |
How is Total Current Liabilities of LAURUS LABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,540 Cr | 13.73 | |
Mar2024 | ₹3,112 Cr | 27.96 | |
Mar2023 | ₹2,432 Cr | -9.28 | |
Mar2022 | ₹2,681 Cr | 9.11 | |
Mar2021 | ₹2,457 Cr | - |
Compare Total Current Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹47,576.5 Cr | 5.5% | 18.2% | 101.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 5.5% |
18.2% |
101.7% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses